Clonality of PIK3CA mutations (mut) and efficacy of PI3K/AKT/mTOR inhibitors (PAMi) in patients (pts) with metastatic breast cancer (MBC).

被引：0
|
作者：
Oliveira, Mafalda
Dienstmann, Rodrigo
Bellet, Meritxell
Perez-Garcia, Jose Manuel
Gomez-Pardo, Patricia
Munoz-Couselo, Eva
Vidal, Maria
Ortega, Vanessa
Soberino, Jesus
Zamora, Esther
Hierro, Cinta
Ruiz, Fiorella
Nuciforo, Paolo
Vivancos, Ana
Cortes, Javier
Saura, Cristina
机构：
[1] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Dept Med Oncol, Breast Canc Grp, Barcelona, Spain
[2] Vall dHebron Inst Oncol, Oncol Data Sci ODysSey Grp, Barcelona, Spain
[3] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Early Clin Drug Dev Grp, Dept Med Oncol, Barcelona, Spain
[4] Vall dHebron Inst Oncol, Mol Pathol Grp, Barcelona, Spain
[5] Vall dHebron Inst Oncol, Canc Genom Grp, Barcelona, Spain
[6] Hosp Ramon & Cajal, Dept Med Oncol, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.528
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
528
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring PIK3CA Mutations
    Janku, Filip
    Wheler, Jennifer J.
    Westin, Shannon N.
    Moulder, Stacy L.
    Naing, Aung
    Tsimberidou, Apostolia M.
    Fu, Siqing
    Falchook, Gerald S.
    Hong, David S.
    Garrido-Laguna, Ignacio
    Luthra, Rajyalakshmi
    Lee, J. Jack
    Lu, Karen H.
    Kurzrock, Razelle
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (08) : 777 - 782
  • [2] PIK3CA Mutations PREDICT RESPONSE TO PI3K/AKT/mTOR INHIBITORS
    不详
    [J]. CANCER DISCOVERY, 2012, 2 (03) : 205 - 205
  • [3] PIK3CA Mutations in Patients with Advanced Cancers Treated with PI3K/AKT/mTOR Axis Inhibitors
    Janku, Filip
    Tsimberidou, Apostolia M.
    Garrido-Laguna, Ignacio
    Wang, Xuemei
    Luthra, Rajyalakshmi
    Hong, David S.
    Naing, Aung
    Falchook, Gerald S.
    Moroney, John W.
    Piha-Paul, Sarina A.
    Wheler, Jennifer J.
    Moulder, Stacy L.
    Fu, Siqing
    Kurzrock, Razelle
    [J]. MOLECULAR CANCER THERAPEUTICS, 2011, 10 (03) : 558 - 565
  • [4] Impact of genomic heterogeneity on PI3K/AKT/mTOR inhibitors (PAMi) efficacy in gynecologic cancer (GYN) patients (pts).
    Freixinos, Victor Rodriguez
    Ruiz-Pace, Fiorella
    Farinas-Madrid, Lorena
    Castro, Ana Christina Garrido
    Villacampa, Guillermo
    Nuciforo, Paolo
    Vivancos, Ana
    Dienstmann, Rodrigo
    Oaknin, Ana
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Screening for PIK3CA, RAS, and RAF mutations in trials with PI3K/AKT/mTOR signaling pathway inhibitors
    Janku, F.
    Tsimberidou, A. M.
    Garrido-Laguna, I.
    Hong, D. S.
    Naing, A. M.
    Falchook, G. S.
    Fu, S.
    Luthra, R.
    Wang, X.
    Kurzrock, R.
    [J]. EJC SUPPLEMENTS, 2010, 8 (07): : 83 - 83
  • [6] PIK3CA, KRAS, and BRAF mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors.
    Janku, F.
    Tsimberidou, A. M.
    Garrido-Laguna, I.
    Hong, D. S.
    Naing, A.
    Falchook, G. S.
    Wheler, J. J.
    Fu, S.
    Piha-Paul, S. A.
    Kurzrock, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Triggering PIK3CA Mutations in PI3K/Akt/mTOR Axis: Exploration of Newer Inhibitors and Rational Preventive Strategies
    Asati, Vivek
    Bharti, Sanjay K.
    Mahapatra, Debarshi Kar
    Asati, Vikas
    Budhwani, Ashok K.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (39) : 6039 - 6054
  • [8] Double PIK3CA mutations in cis enhance PI3Kα oncogene activation and sensitivity to PI3Kα inhibitors in breast cancer
    Vasan, N.
    Razavi, P.
    Johnson, J. L.
    Shao, H.
    Reznik, E.
    Smith, M. L.
    Sebra, R.
    Cantley, L. C.
    Scaltriti, M.
    Baselga, J.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 1 - 1
  • [9] PIK3CA copy-number gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancer
    Amato, Ottavia
    Buisseret, Laurence
    Gebhart, Geraldine
    Plouznikoff, Nicolas
    Larsimont, Denis
    Awada, Ahmad
    Piccart, Martine
    Aftimos, Philippe
    [J]. COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2023, 9 (02):
  • [10] PIK3CA alterations in metastatic breast cancer (mBC)
    Albanell, J.
    Casadevall, D.
    Sokol, E. S.
    Albacker, L. A.
    Elvin, J. A.
    Vergilio, J-A.
    Killian, J. K.
    Ngo, N.
    Lin, D.
    Ramkissoon, S.
    Severson, E.
    Ali, S. M.
    Schrock, A. B.
    Chung, J.
    Reddy, P.
    Miller, V. A.
    Alexander, B. M.
    McGregor, K.
    Ross, J. S.
    Leyland-Jones, B.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 104 - +
12345